Laboratory Research Assistant, Molecular Radiopharmacy, INRASTES, NCSR “Demokritos”
Emmanouil Lymperis is a chemist, holding a master degree in organic synthesis, and is a PhD candidate in the Department of Pharmacy at the Aristotle University of Thessaloniki. The PhD Thesis is implemented at the National Center for Research in Natural Sciences “Demokritos”, under the supervision of Dr. Berthold Nock. Mr. Lymperis has worked as a scientific associate with a fixed-term contract in Molecular Radiopharmacy, INRASTES, NCSR “Demokritos”, in collaboration with the Department of Nuclear Medicine of Erasmus MC, University of Rotterdam, Rotterdam, The Netherlands, with research aiming at the development and evaluation of radiolabelled peptides applied in oncology. He was member of the research team, which in 2013 in collaboration with Erasmus MC, received the prestigious “Marie Curie Award” (https://www.eanm.org/congresses-events/awards-grants/winners/) for their work on the “in situ” stabilization of radiopeptides in vivo by co-administration of key-protease inhibitors.
Education and Certifications
Present PhD Candidate, Department of Pharmacy, Aristotle University of Thessaloniki in collaboration with the National Center for Research in Natural Sciences “Demokritos”.
2010 Master Diploma in Organic Synthesis, Department of Chemistry, Aristotle University of Thessaloniki.
2008 1st study cycle of Oenology, University of Bordeaux 2, France.
2007 Degree in Chemistry, Department of Chemistry, Aristotle University of Thessaloniki.
Professional and Research Experience
Present Chemist, HELLENIC PETROLEUM SA, Elefsis Industrial Plant, Department of Chemistry.
» Laboratory Associate, Molecular Radiopharmaceutical, INRASTES, NCSR “Demokritos”.
2012-2015 Scientific Associate, Molecular Radiopharmaceuticals, INRASTES, NCSR “Demokritos”.
2011-2012 Professor, SCE Akmi, with subject the Drug Control Methods
Publications in international journals with judges: 11
The research project “Phase I clinical trial using a novel CCK-2/gastrin receptor-localizing radiolabelled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma” coded ERANET TRANSCAN-GRAN-T-MTC (Ε11820) with a 3-year duration (20...
The research project “(Radio)diagnostic - (Radio)therapeutic Peptides and Peptide-like Molecules for Use in Oncology” coded Ε11461 with a 7-year duration (2007-2014) is coordinated by B. A. Nock. It concerns a research cooperation of the Molecular Radiopharmacy team with the Department of Nuclear Me...